GEFEN Biomed investments is a publicly traded company (TASE) investing in biotechnology and medical technologies. By holding two incubators (ATI and Meytav), GEFEN Biomed’s risk management uses the leverage of funds through the incubators program of the Israeli chief scientist, focusing on the health-care area. GEFEN developed expertise, experience and connections that benefited our 40 young and mature portfolio companies.
Gefen via its incubators is investing in early stage technology ventures, we managed to form alliances and collaborations with funding partners such as small private groups, VCs and strategic partners. Our close attention and experience help our companies to utilize limited funds in the most efficient manner to achieve milestones.